Access!, AAM’s annual meeting for the generics and biosimilars industry, brings policymakers, influential speakers and industry leaders together to share knowledge and ideas. This year virtual Access! is May 26-27.
Physicians and hospitals play a critical role in biosimilar adoption. This paper highlights the importance of examining ways to remove obstacles that may discourage providers from utilizing lower-cost biosimilars with their patients.
This paper examines the challenges to market sustainability for generic and biosimilar medicines that have cleared the regulatory and patent hurdles to obtain FDA approval and launch into the U.S. market.